Evidence map›Paper›PMID 30613024›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2018

[Bloodstream infections with

Yiming Zhong, Xiaohe Zhang, Wenen Liu, Fang Yang, Qun Yan, Qingxia Liu, Yanming Li, Hongling Li, Mingxiang Zou

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yiming ZhongDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.
Xiaohe ZhangDepartment of Laboratory Medicine, Xiangya School of Medicine, Central South University, Changsha 410013, China.
Wenen LiuDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.
Fang YangDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.
Qun YanDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.
Qingxia LiuDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.
Yanming LiDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.
Hongling LiDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.
Mingxiang ZouDepartment of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the phylogenetics and prevalence of bloodstream infections with

methodsNon-duplicate

resultsThe phylogenetic group analysis showed a domination by group B2 (41.0%[59/144]), followed by group F, group B1 and group E, which accounted for 16.7%(24/144), 13.9%(20/144), and 13.2% (19/144), respectively.Nine strains (6.3%) of

conclusionsThe most common phylogenetic groups of

Indexed as

Escherichia coliAnti-Bacterial AgentsBacteremiaChinaDrug Resistance, BacterialEscherichia coli InfectionsGenotypeHumansMicrobial Sensitivity TestsMolecular EpidemiologyPhylogenySpecies SpecificityAnti-Bacterial Agentsantimicrobial resistancebloodstream infectionclinical featuresEscherichia coliphylogenetic groupsST131

Identifiers

PMID30613024
PMCPMC6744214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.